Gonzalez, N.; Perez Küper, M.; Garcia Fallit, M.; Nicola Candia, A.J.; Peña Agudelo, J.A.; Suarez Velandia, M.; Romero, A.C.; Videla-Richardson, G.A.; Candolfi, M.
Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition. Biology 2025, 14, 572.
https://doi.org/10.3390/biology14050572
AMA Style
Gonzalez N, Perez Küper M, Garcia Fallit M, Nicola Candia AJ, Peña Agudelo JA, Suarez Velandia M, Romero AC, Videla-Richardson GA, Candolfi M.
Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition. Biology. 2025; 14(5):572.
https://doi.org/10.3390/biology14050572
Chicago/Turabian Style
Gonzalez, Nazareno, Melanie Perez Küper, Matias Garcia Fallit, Alejandro J. Nicola Candia, Jorge A. Peña Agudelo, Maicol Suarez Velandia, Ana Clara Romero, Guillermo Agustin Videla-Richardson, and Marianela Candolfi.
2025. "Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition" Biology 14, no. 5: 572.
https://doi.org/10.3390/biology14050572
APA Style
Gonzalez, N., Perez Küper, M., Garcia Fallit, M., Nicola Candia, A. J., Peña Agudelo, J. A., Suarez Velandia, M., Romero, A. C., Videla-Richardson, G. A., & Candolfi, M.
(2025). Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition. Biology, 14(5), 572.
https://doi.org/10.3390/biology14050572
